Trevena
TRVN
#11371
Rank
S$0 M
Marketcap
S$0.0006450
Share price
0.00%
Change (1 day)
-95.07%
Change (1 year)

Earnings for Trevena (TRVN)

Earnings in 2024 (TTM): -S$41.19 Million

According to Trevena's latest financial reports the company's current earnings are S$0.54 Million. In 2023 the company made an earning of -S$46.87 Million, an increase over its 2022 earnings that were of -S$67.62 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevena from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$41.19 Million-12.12%
2023 -S$46.87 Million-30.69%
2022 -S$67.62 Million1.38%
2021 -S$66.7 Million78.04%
2020 -S$37.47 Million21.3%
2019 -S$30.89 Million-13.91%
2018 -S$35.88 Million-59.75%
2017 -S$89.13 Million-31.77%
2016 -S$0.14 Billion101.73%
2015 -S$64.76 Million1.14%
2014 -S$64.03 Million114.83%
2013 -S$29.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
S$14.25 B-35,687.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$8.67 B-21,747.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-S$0.11 Billion 155.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-S$1.01 Billion 2,404.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-S$13.28 Million-66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-S$81.01 Million 102.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-S$0.81 Billion 1,918.69%๐Ÿ‡บ๐Ÿ‡ธ USA